Pancreatic Cancer Research

ResearcherMayo ClinicNo recent work listed

Jair Machado Espíndola‐Netto

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0387-5059; OpenAlex author ID A5017306698. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2016: 1 paper · 2017: 1 paper

Papers 2

  1. Preclinical efficacy of the novel competitive NAMPT inhibitor STF-118804 in pancreatic cancer. Co-author DOI 10.18632/oncotarget.18841↗
  2. SIRT1-Activating Compounds (STAC) Negatively Regulate Pancreatic Cancer Cell Growth and Viability Through a SIRT1 Lysosomal-Dependent Pathway. First author DOI 10.1158/1078-0432.ccr-15-1760↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Eduardo N Chini · 2 shared papers, 2016–2017 · strength 0.13
  2. Claudia C.S. Chini · 2 shared papers, 2016–2017 · strength 0.13
  3. Krishnendu Pal · 1 shared paper, 2017 · strength 0.07
  4. Debabrata Mukhopadhyay · 1 shared paper, 2017 · strength 0.07
  5. Jin‐San Zhang · 1 shared paper, 2016 · strength 0.06
  6. Daniel D. Billadeau · 1 shared paper, 2016 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.